Augustine W Kang1, Audrey A DeBritz2, Ariel Hoadley3, Courtney DelaCuesta2, Mary Walton4, Linda Hurley4, Rosemarie Martin2. 1. Center for Alcohol and Addiction Studies, Brown University School of Public Health, Providence, RI, United States; Stanford University School of Medicine, Stanford, CA, United States. Electronic address: Augustine_Kang@brown.edu. 2. Center for Alcohol and Addiction Studies, Brown University School of Public Health, Providence, RI, United States. 3. Center for Alcohol and Addiction Studies, Brown University School of Public Health, Providence, RI, United States; Department of Social and Behavioral Sciences, Temple University College of Public Health, Philadelphia, PA, United States. 4. CODAC Behavioral Healthcare, Inc., Cranston, RI, United States.
Abstract
OBJECTIVE: The COVID-19 pandemic catalyzed the relaxation of regulations surrounding Medication for Opioid Use Disorders (MOUD) treatment, including a shift from in-person to telehealth counseling services adjunct to MOUD treatment. We examine how patient-level barriers impact their counseling experiences. METHODS: We examine data from n = 264 participants who completed a cross-sectional survey regarding their experiences with telephone counseling adjunct to MOUD between July to November 2020. Variables examined include: convenience and satisfaction with telephone counseling, comfort and change in relationship with counselor, and how telephone counseling helped with anxiety, depression, anger, substance use, and recovery. Participants also listed the barriers they faced when using telephone counseling. RESULTS: Thirty-one percent of the sample (n = 81) reported experiencing one or more barriers to telephone counseling. Satisfaction with counseling, perceived convenience, comfort, and beneficial effects of counseling on substance use were associated with increased odds of reporting no barriers (range of p.038 to <0.001). CONCLUSIONS: Many participants reported barriers to telehealth counseling, and these barriers were in turn associated with poorer counseling experiences. PRACTICE IMPLICATIONS: Many treatment providers plan to integrate telehealth service provision in their healthcare delivery model, but more research on patient-level barriers and its impact on treatment is needed.
OBJECTIVE: The COVID-19 pandemic catalyzed the relaxation of regulations surrounding Medication for Opioid Use Disorders (MOUD) treatment, including a shift from in-person to telehealth counseling services adjunct to MOUD treatment. We examine how patient-level barriers impact their counseling experiences. METHODS: We examine data from n = 264 participants who completed a cross-sectional survey regarding their experiences with telephone counseling adjunct to MOUD between July to November 2020. Variables examined include: convenience and satisfaction with telephone counseling, comfort and change in relationship with counselor, and how telephone counseling helped with anxiety, depression, anger, substance use, and recovery. Participants also listed the barriers they faced when using telephone counseling. RESULTS: Thirty-one percent of the sample (n = 81) reported experiencing one or more barriers to telephone counseling. Satisfaction with counseling, perceived convenience, comfort, and beneficial effects of counseling on substance use were associated with increased odds of reporting no barriers (range of p.038 to <0.001). CONCLUSIONS: Many participants reported barriers to telehealth counseling, and these barriers were in turn associated with poorer counseling experiences. PRACTICE IMPLICATIONS: Many treatment providers plan to integrate telehealth service provision in their healthcare delivery model, but more research on patient-level barriers and its impact on treatment is needed.
Authors: Joseph K Eibl; Graham Gauthier; David Pellegrini; Jeffery Daiter; Michael Varenbut; John C Hogenbirk; David C Marsh Journal: Drug Alcohol Depend Date: 2017-05-17 Impact factor: 4.492
Authors: Haiden A Huskamp; Alisa B Busch; Jeffrey Souza; Lori Uscher-Pines; Sherri Rose; Andrew Wilcock; Bruce E Landon; Ateev Mehrotra Journal: Health Aff (Millwood) Date: 2018-12 Impact factor: 6.301
Authors: Van L King; Kenneth B Stoller; Michael Kidorf; Kori Kindbom; Steven Hursh; Thomas Brady; Robert K Brooner Journal: J Subst Abuse Treat Date: 2008-09-04
Authors: Jaclyn M W Hughto; Lisa Peterson; Nicholas S Perry; Alex Donoyan; Matthew J Mimiaga; Kimberly M Nelson; David W Pantalone Journal: J Subst Abuse Treat Date: 2020-10-09
Authors: Augustine W Kang; Mary Walton; Ariel Hoadley; Courtney DelaCuesta; Linda Hurley; Rosemarie Martin Journal: Healthcare (Basel) Date: 2021-06-02
Authors: Rumi Chunara; Yuan Zhao; Ji Chen; Katharine Lawrence; Paul A Testa; Oded Nov; Devin M Mann Journal: J Am Med Inform Assoc Date: 2021-01-15 Impact factor: 4.497
Authors: Siqin Ye; Ian Kronish; Elaine Fleck; Peter Fleischut; Shunichi Homma; David Masini; Nathalie Moise Journal: J Gen Intern Med Date: 2020-10-26 Impact factor: 5.128